These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10936807)

  • 41. AAMI releases new standards for dialysate for hemodialysis.
    Curtis J
    Nephrol News Issues; 2004 Dec; 18(13):54-6. PubMed ID: 15643823
    [No Abstract]   [Full Text] [Related]  

  • 42. Detection of bacteria in dialysate and its antibody in long-term hemodialysis patients.
    Yamagami S; Adachi T; Sugimura T; Kishimoto T; Maekawa M; Niwa M; Shaldon S
    ASAIO Trans; 1989; 35(3):331-3. PubMed ID: 2597475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis.
    Arizono K; Nomura K; Motoyama T; Matsushita Y; Matsuoka K; Miyazu R; Takeshita H; Fukui H
    Blood Purif; 2004; 22 Suppl 2():26-9. PubMed ID: 15655319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microbiologic purity of dialysate: rationale and technical aspects.
    Canaud B; Bosc JY; Leray H; Morena M; Stec F
    Blood Purif; 2000; 18(3):200-13. PubMed ID: 10859423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrapure dialysate reduces dose of recombinant human erythropoietin.
    Schiffl H; Lang SM; Bergner A
    Nephron; 1999; 83(3):278-9. PubMed ID: 10529639
    [No Abstract]   [Full Text] [Related]  

  • 46. Does ultrapure dialysate prevent the development of biofilm in dialysis therapy?
    Penders C; Kooman JP; Stobberingh EE; van Der Sande FM; Frederik PM; Leunissen KM
    Nephrol Dial Transplant; 2001 Jul; 16(7):1522-4. PubMed ID: 11427668
    [No Abstract]   [Full Text] [Related]  

  • 47. Removal of Cell-Activating Substances Using Dialyzers With Various Permeability Profiles.
    Latosinska A; Hulko M; Speidel R; Mischak H; Storr M; Krause B
    Artif Organs; 2018 Jan; 42(1):78-87. PubMed ID: 28744941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction.
    Friedrich B; Alexander D; Janessa A; Häring HU; Lang F; Risler T
    Kidney Int; 2006 Dec; 70(12):2124-30. PubMed ID: 17063178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How do changes in water quality and dialysate composition affect clinical outcomes?
    Hoenich NA; Levin R; Ronco C
    Blood Purif; 2009; 27(1):11-5. PubMed ID: 19169011
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Water treatment for hemodialysis.
    Ismail N; Becker BN; Hakim RM
    Am J Nephrol; 1996; 16(1):60-72. PubMed ID: 8719767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new method of post-dialysis blood urea sampling: the 'stop dialysate flow' method.
    Geddes CC; Traynor J; Walbaum D; Fox JG; Mactier RA
    Nephrol Dial Transplant; 2000 Apr; 15(4):517-23. PubMed ID: 10727547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical relevance of cytokine production in hemodialysis.
    Pertosa G; Grandaliano G; Gesualdo L; Schena FP
    Kidney Int Suppl; 2000 Aug; 76():S104-11. PubMed ID: 10936806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
    Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R
    ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897
    [No Abstract]   [Full Text] [Related]  

  • 54. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
    Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
    Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Standards revised for water treatment, concentrate labeling.
    Sadler JH
    Nephrol News Issues; 1999 Jun; 13(6):29-30. PubMed ID: 10603846
    [No Abstract]   [Full Text] [Related]  

  • 56. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In search of sterile, endotoxin-free dialysate.
    Gault MH; Duffett AL; Murphy JF; Purchase LH
    ASAIO J; 1992; 38(3):M431-5. PubMed ID: 1457896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis.
    Lindsay RM; Bene B; Goux N; Heidenheim AP; Landgren C; Sternby J
    Am J Kidney Dis; 2001 Sep; 38(3):565-74. PubMed ID: 11532690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Easy production of sterile, pyrogen-free dialysate.
    Erley CM; von Herrath D; Hartenstein-Koch K; Kutschera D; Amir-Moazami B; Schaefer K
    ASAIO Trans; 1988; 34(3):205-7. PubMed ID: 3196509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood components influence cytokine induction by bacterial substances.
    Schindler R; Eichert F; Lepenies J; Frei U
    Blood Purif; 2001; 19(4):380-7. PubMed ID: 11574734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.